UNICK FIX-A-FORM AND PRINTERS | GLENMARK PHARMA | UNICK FIX-A-FORM AND PRINTERS/ GLENMARK PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 27.9 | -35.4 | - | View Chart |
P/BV | x | 1.1 | 3.2 | 35.6% | View Chart |
Dividend Yield | % | 0.0 | 0.2 | - |
UNICK FIX-A-FORM AND PRINTERS GLENMARK PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
UNICK FIX-A-FORM AND PRINTERS Mar-23 |
GLENMARK PHARMA Mar-23 |
UNICK FIX-A-FORM AND PRINTERS/ GLENMARK PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 59 | 487 | 12.1% | |
Low | Rs | 32 | 349 | 9.0% | |
Sales per share (Unadj.) | Rs | 120.5 | 460.4 | 26.2% | |
Earnings per share (Unadj.) | Rs | 4.1 | 13.4 | 30.5% | |
Cash flow per share (Unadj.) | Rs | 11.2 | 35.0 | 32.0% | |
Dividends per share (Unadj.) | Rs | 0 | 2.50 | 0.0% | |
Avg Dividend yield | % | 0 | 0.6 | 0.0% | |
Book value per share (Unadj.) | Rs | 53.9 | 335.1 | 16.1% | |
Shares outstanding (eoy) | m | 5.49 | 282.17 | 1.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.4 | 0.9 | 41.3% | |
Avg P/E ratio | x | 11.1 | 31.3 | 35.4% | |
P/CF ratio (eoy) | x | 4.0 | 11.9 | 33.8% | |
Price / Book Value ratio | x | 0.8 | 1.2 | 67.3% | |
Dividend payout | % | 0 | 18.7 | 0.0% | |
Avg Mkt Cap | Rs m | 248 | 117,953 | 0.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 90 | 27,810 | 0.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 662 | 129,901 | 0.5% | |
Other income | Rs m | 5 | 3,168 | 0.2% | |
Total revenues | Rs m | 667 | 133,069 | 0.5% | |
Gross profit | Rs m | 88 | 15,125 | 0.6% | |
Depreciation | Rs m | 39 | 6,113 | 0.6% | |
Interest | Rs m | 24 | 3,496 | 0.7% | |
Profit before tax | Rs m | 30 | 8,685 | 0.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 7 | 4,911 | 0.2% | |
Profit after tax | Rs m | 22 | 3,774 | 0.6% | |
Gross profit margin | % | 13.3 | 11.6 | 113.9% | |
Effective tax rate | % | 25.0 | 56.5 | 44.2% | |
Net profit margin | % | 3.4 | 2.9 | 116.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 301 | 98,737 | 0.3% | |
Current liabilities | Rs m | 287 | 50,455 | 0.6% | |
Net working cap to sales | % | 2.1 | 37.2 | 5.7% | |
Current ratio | x | 1.0 | 2.0 | 53.6% | |
Inventory Days | Days | 4 | 7 | 57.8% | |
Debtors Days | Days | 72,349,839 | 115 | 62,823,389.4% | |
Net fixed assets | Rs m | 402 | 76,920 | 0.5% | |
Share capital | Rs m | 55 | 282 | 19.4% | |
"Free" reserves | Rs m | 241 | 94,281 | 0.3% | |
Net worth | Rs m | 296 | 94,563 | 0.3% | |
Long term debt | Rs m | 89 | 38,521 | 0.2% | |
Total assets | Rs m | 705 | 175,658 | 0.4% | |
Interest coverage | x | 2.3 | 3.5 | 64.7% | |
Debt to equity ratio | x | 0.3 | 0.4 | 73.6% | |
Sales to assets ratio | x | 0.9 | 0.7 | 126.8% | |
Return on assets | % | 6.6 | 4.1 | 158.3% | |
Return on equity | % | 7.6 | 4.0 | 189.8% | |
Return on capital | % | 14.0 | 9.2 | 152.5% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 46,464 | 0.0% | |
Fx outflow | Rs m | 0 | 12,712 | 0.0% | |
Net fx | Rs m | 0 | 33,751 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 44 | 6,254 | 0.7% | |
From Investments | Rs m | -27 | -5,285 | 0.5% | |
From Financial Activity | Rs m | -16 | -775 | 2.1% | |
Net Cashflow | Rs m | 0 | 325 | 0.1% |
Indian Promoters | % | 71.6 | 46.6 | 153.5% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.5 | 34.8 | 1.3% | |
FIIs | % | 0.0 | 21.4 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 28.4 | 53.4 | 53.3% | |
Shareholders | 1,622 | 199,451 | 0.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare UNICK FIX-A-FORM AND PRINTERS With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | UNICK FIX-A-FORM AND PRINTERS | Glenmark Pharma | S&P BSE TECK |
---|---|---|---|
1-Day | 4.56% | 0.05% | -0.26% |
1-Month | 21.23% | 13.00% | -0.74% |
1-Year | 56.84% | 107.14% | 29.95% |
3-Year CAGR | 31.01% | 25.06% | 10.57% |
5-Year CAGR | 20.58% | 10.85% | 15.11% |
* Compound Annual Growth Rate
Here are more details on the UNICK FIX-A-FORM AND PRINTERS share price and the Glenmark Pharma share price.
Moving on to shareholding structures...
The promoters of UNICK FIX-A-FORM AND PRINTERS hold a 71.6% stake in the company. In case of Glenmark Pharma the stake stands at 46.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of UNICK FIX-A-FORM AND PRINTERS and the shareholding pattern of Glenmark Pharma.
Finally, a word on dividends...
In the most recent financial year, UNICK FIX-A-FORM AND PRINTERS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.
You may visit here to review the dividend history of UNICK FIX-A-FORM AND PRINTERS, and the dividend history of Glenmark Pharma.
For a sector overview, read our media sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.